BRN.AX is trading 6.7% up now at $0.16 after announcing the commercial availability and initial production shipments of its AKD1500 neuromorphic AI chips.
- The move marks a clear transition from R&D to full-scale commercialization, with production quantities already shipping to customers across defense and wearable edge AI applications.
- Developed in partnership with GlobalFoundries, the milestone has fueled renewed investor optimism regarding BrainChipβs commercialization roadmap and future product revenue.